eHealth in Drug Discovery and Disease Research
Information technology is transforming the way healthcare is developed, delivered and documented, making available detailed information such as phenotypes and genetic data and holding the promise of making a great contribution to medical research. A part of this fast changing landscape is eHealth. eHealth is becoming increasingly important for the pharmaceutical industry, offering remarkable enhancement opportunities for the clinical research sector. Electronic health records (EHRs), interconnected through healthcare networks, have the potential to interact richly with research platforms while complying with all applicable legal, regulatory and ethical standards and policies. This chapter explores the great potential of eHealth to the field of drug discovery and development.
KeywordsBusiness Model Drug Discovery Personalise Medicine Electronic Health Record Health Information Technology
Unable to display preview. Download preview PDF.
- CMR International (2012), Pharmaceutical Fact book 2012. ISBN: 978-0-9551411-9-5.Google Scholar
- Curtis, L.H., Weiner, M.G., Boudreau, D.M., Cooper, W.O., Daniel, G.W., Nair, V.P., Raebel, M.A., Beaulieu, N.U., Rosofsky, R., Woodworth, T.S. and Brown, J.S. (2012), “Design considerations, architecture, and use of the Mini-Sentinel distributed data system”, Pharmacoepidemiology and Drug Safety 21: 23–31.CrossRefGoogle Scholar
- Hermosilla, I., Kouskoumvekaki, I., Shublaq, N. and Lopez Alonso, V. (2013) Prospective analysis on Biomedical Informatics enabling personalised medicine, INBIOMED Vision Consortium. (Available at: http://www.inbiomedvision.eu/PDF/Prospective.pdf.)
- Kalra, D., Schmidt, A., Potts, H.W.W., Dupont D., Sundgren, M. and De Moor, G. (2011), “Case report from the EHR4CR project: a European survey on electronic health records systems for clinical research”, iHealth Connections 1(2): 108–113.Google Scholar
- Microsoft Research (2006), Towards Science 2020, Cambridge, UK. (Available at http://research.microsoft.com/towards202Oscience.)
- Olsson, M. (2011), The Data Explosion and the Future of Health: What Every Decision-Maker in the Health and Healthcare Industries Need To Know about the Coming Revolution, Kairos Future, Sweden. (Available at: http://www.kairosfuture.com/en/publications/dataexplosion-and-future-health.)
- Paul, S.M., Mytelka, D.S., Dunwiddie, CT., Persinger, CT., Munos, B.H., Lindborg, S.R. and Schact, A.L. (2010), “How to improve R&D productivity: the pharmaceutical industry’s grand challenge”, Nature Reviews Drug Discovery 9(3): 203–214.Google Scholar
- Sundgren, M. (2011), “Connection power in the new information landscape”, European Pharmaceutical Contractor Quarterly June: 71–73.Google Scholar
- Sundgren, M., Wilson, P. and de Zegher, I. (2009), “Making the most of the Electronic Age”, European Pharmaceutical Contractor (3): 18–21.Google Scholar
- Zott, C., Amit, R. and Massa, L. (2010), The Business Model: Theoretical Roots, Recent Developments, and Future Research. Working Paper WP-862, IESE Business School, University of Navarra, 1–45.Google Scholar